3 курс / Общая хирургия и оперативная хирургия / Кадыров_Б_А_Сравнение_результатов_чрескожных_коронарных_вмешательств

24.Aoki J, Hoye A, Staferov A et al. SES implantation for chronic total occlusion of the LMCA. J of Interventional Cardiology 2005; 18: 65-69.

25.Aramplatzis C.A., Lemos P.A., Hoya A. et al. Elective SES Implantation for LMCA Disease: Six-Month Angiographic Follow-up and 1-Year Clinical Outcome. Catheter Cardiovasc Interv. 2004; 62: р. 292 – 296.

26.Bagrat Alekyan, Yuri Buziashvili,Elena Golukhova, Tatiana Nikitina, Anton Staferov, Narek Zakarian, Karen Petrosian, Bahram Kadyrov. Results of stenting in the treatment of patients with the unprotected LMCA disease. The 61 Internathional Congress of he European Society of Cardiovascular Surgery ESCVS.// Abstrak book. The Journal of Cardiovascular Surgery. Volume

53.Suppl.I to № 2 .April 2012

27.Bayet G., Commeau P., Sainsous J. et al. Stenting in Unprotected LMCA: 1- Year Follow-Up in 240 Consecutive Elective Procedures. Am J Cardiol. 2001; 88; 5 (suppl 1): p. 4 – 6.

28.Bedson Jose Lopes de Sa, Barbosa J.B. et al. PCI of Unprotected LMCA in a Patient with Cardiogenic Shock. Arq Bras Cardiol. 1999; 73 (3): p. 302 – 304.

29.Biondi-Zoccai GG, Lotrionte M, Moretti C et al. A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous DES for unprotected left main coronary artery disease. Am Heart J. 2008 Feb;155(2):274-83.

30.Black A., Cortina R., Bossi I. et al. Unprotected LMCA Stenting: Correlates of Midterm Survival and Impact of Pation selection. J Am Coll Cardiol. 2001; 37: р. 382 – 388.

31.Boccalatte M., Sousa P., Hasan Ali H. et al. Unprotected Left Main Coronary Artery Stenting: Longand Medium-term Outcomes. Am J Cardiol. 2001; 88 (supp 1 5A): 6G. Abstract.

32.Boudriot E, Thiele H, Walther T, Liebetrau C,Randomized comparison of PCI with SES versus coronary artery bypass grafting in unprotected left main stem

stenosis. J Am Coll Cardiol. 2011 Apr 26;57(17):1792

131

33.Brener SJ, Galla JM, Bryant R III et al. Comparison of PCI Versus CABG Revascularization of Severe Unprotected LMCA Stenosis in Matched Patients. Am J Cardiol. 2008;101:169-172.

34.Buszman PE, Kiesz SR, Bochenek A et al. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. J Am Coll Cardiol.2008 Feb 5;51(5):538-45.

35.Cammeau P., Barragan P., Roquebert R.O. et al. Left Main Coronary Stenting: Long-Term Follow-Up. Am J Cardiol. 2004; 94 (suppl 6A): 3E.

36.Campeau L., Corbara F., Crochet D. et al. LMCA stenosis: the influence of CABG surgery on survival. Circulation. 1978; 57 (6): р. 1111 – 1115.

37.Caracciolo E.A., Sopco G. et al. Comparison of surgical and medical group survival in patients with left main coronary artery disease. Long term CASS experience. Circulation. 1995; 91: р. 2325 – 2334.

38.Chaitman B., Fisher L.D., Bourassa M.G. et al. Effect of CABG on Survival Patterns in Subsets of Patients with LMCA Disease. Am J Cardiol. 1981; 48 (4): р. 765 – 777.

39.Chauhan A., Buller C.E. et al. Clinical outcome in LM coronary artery PTCA and stenting. The J of Invasive Cardiology. 1996; 8 (1): p. 41.

40.Colombo A., Morice M. et al. Randomized Study Evaluate SES Implanted at coronary Bifurcation Lesions. // Circulation. -2004. –Vol. 109. –P. 1244-1249

41.Chieffo A., Orlic D., Airoldi F. Early and mid-term results of Cypher stents in unprotected left main. J Am Coll Cardiol. 2004; 43 (5): р. 1116 – 1118

42.Chieffo A., Stankovic G., Bonizzoni E. Early and mid–term results of drugeluting stent implantation in unprotected LM. Circulation. 2005; 111 (6): p. 791 – 795.

43.Сolomvo A.,Chieffo A, Morici N, Maisano F et al. DES Implantation vs. CABG for Unprotected Left Main Stenosis. Circulation 2006 113: 2542-2547

132

44.Chieffo A, et al. Favorable long-term outcome after DES implantation in nonbifurcation lesions that involve unprotected LMCA: a multicenter registry. Circulation.2007 Jul 10; 116 (2):158-62.

45.Cohen M.V., Main left coronary artery disease. Clinical experience from 1964

–1974. Circulation 1975; 52: р. 275 – 285.

46.Crowley S.T., Morrison D.A., Percutaneous transluminal coronary angioplasty of the LMCA in patients with rest angina. Cathet Cardiovasc Diagn. 1994; 33: р. 103 – 107.

47.Dacosta A., Tardy B., Favre J.P. et al. Left Main Coronary Artery Disease. Arch Mal Coeur Vaiss. 1994; 87 (9): р. 1225 – 1232.

48.De Lezo J.S., Medina A., Romero M. et al. Predictors of Restenosis Following Unprotected LMCA Stenting. Am J Cardiol. 2001; 88: р. 308 – 310.

49.De Lezo JS, Medina A, Pan M, et al. Rapamycin-eluting stents for the

treatment of unprotected LMCA disease. Am Heart J 2004;148:481-5.

50. De Mots H., Rosch J. et al. LMCA Disease. Risks of angiography, Importance of Coexisting Disease of Other Coronary arteries and Effect of Revascularization. Am J Cardiol. 1975; 36 (2): р. 136 – 141.

51.Eagle KA.., Guyton R.A., Davidoff R. et al. ACC/AHA 2004 Guideline Update for CABG Surgery: Summary Article A Report of the ACC/AHA Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines CABG). Circulation. 2004; 110: р. 1168 – 1176.

52.Ellis G.S., Nobuyoshi M. et al. Contemporary Percutaneous Treatment of Unprotected LMCA Stenoses. Initial Results From a Multicenter Registry Analysis 1994–1996. Circulation. 1997; 96: р. 3867 – 3872.

53.Fajadet J., Black A.J., Hayerizadeh B.F. et al. Unprotected Left Main Stenting. The Paris Course on revascularization. 2002. p. 63 – 80.

54.Favaloro R.G., Effler D.B., Groves L.K. et al. Severe segmental obstruction of the LMCA and its Divisions: Surgical treatment by the sephenous vein graft

technique. J. Thorac. Cardiovasc. Surg. 1970; 60 (4): р. 469 – 482.

133

55.Fearon WF, Coronary artery anatomy for the interventionalist. In: King SB, Yeung AC edited: Interventional cardiology. 2007, McGraw-Hill Co, NY. P. 3-12.

56.Garsia–Cantu E., Spaulding C., Corcos T. et al. Stent implantation in acute MI. Am J Cardiol 1996; 77: р. 451 – 454.

57.Gotsman N.S., Baket A. Obstruction of the LMCA - the artery of sudden death. S.A. Med. J. 1973; 47: р. 641 – 644.

58.Gruentzig A. Transluminal dilatation of coronary artery stenosis (letter).

Lancet. 1978; 1: р. 263.

59.Gruentzig A.R., Senning A., Siegnenthaler W.E. Nonoperative dilatation of coronary-artery stenosis. N Engl J Med. 1979; 301: р. 61 – 67.

60.Guidelines for PTCA. A report of the American College of Cardiology. J Am

Coll Cardiol. 1988; 12: р. 529 – 545.

61.Hands M.E., Rutherford J.D., Muller J.E. et al. The in-hospital development of cardiogenic shock after MI: incidence, predictors of occurrence, outcome and prognostic factors. The MILIS Study Group. J Am Coll Cardiol. 1989; 14 (1): р. 40 – 46; discussion р. 47 – 48.

62.Hendler A, Kaluski E, Blatt A, et al. PCI of unprotected LMCA in the emergent/urgent setting. J Invasive Cardiol.2007 May;19(5):202-6.

63.Herric J. Clinical features of sudden obstruction of the coronary arteries. JAMA. 1912; 59: р. 2015.

64.Hun Sik Park, MD,Taehoon Ahn,MD,Seung-Jung Park MD, Long-Term Safety and Efficacy of PCI Versus CABG for Unprotected LMCA Disease : 5-Year Results From the MAIN-COMPARE (Revascularization for Unprotected LMCA Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) Registry. Journal of the American College of Cardiology. Volume 56, Issue 2, 6 July 2010, Pages 117

–124

134

65.Hodgson JM, Stone GW, Lincoff MA et al. Late stent thrombosis: considerations and practical advise for the use of DES: a report from the SCAI DES Task Forse. Cath and Cardiovasc Interv 2007; 69: 327-333.

66.Holm F., Lubanda J.C., Semrad M. et al. Main clinical and surgical determinants of in-hospital mortality after surgical revascularization of LMCA: 2 year retrospective study (1998 - 1999). J Mal Vasc. 2004; 29 (2): р. 89 – 93.

67.Huang Z., Nakamura S., Angiographic Follow-up of Elective PCI in De Novo Lesions in the Unprotected LMCA. TCT 2003. Abstract.

68.Huang HW, Brent BN, Trends in percutaneous versus surgical revascularization of unprotected LMCA stenosis in the DES era: a report from the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). Catheter Cardiovasc Interv. 2006 Dec;68(6):867-72.

69.Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of DES. JAMA 2005;293:2126 - 30.

70.Jaffe R, Strauss BH. Late and very late thrombosis of DES : evolving concepts and perspectives. J Am Coll Cardiol 2007;50:119-27.

71.Karam C., Fajadet J. et al. Six-mounth follow-up of unprotected LMCA stenting. Circulation. 1996; 94 (Suppl 1): р. I 627.

72.Kastrati A, Pache J et al. Analysis of 14 trials comparing SES with BMS. N Engl J Med 2007; 356: 1030-1039.

73.Kelley MP, Klugherz BD, Hashemi SM, et al. One-year clinical outcomes of protected and unprotected LMCA stenting. Eur Heart J 2003;24:1554-9.

74.Khaja F., Easley R.M. et al. Left Main CA Lesions. Risks of Catheterization, Exercise Testing and Surgery. Circulation. 1974; 49 – 50 (suppl II): р. 136 – 140.

75.Khattab AA, Hamm CW, Senges J, et al. SES treatment for unprotected

versus protected left main coronary artery disease in widespread clinical

135

routine: 6-month and 3-year clinical follow-up results from the prospective

multicentre German Cypher Registry. Heart.2007 Oct;93(10):1251-5.

76.King SB III, Hirshfeld JW jr et al. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for PCI. Catheterization and Cardiovascular Interventions JACC 2007; 71: E1–E40.

77.Korzeniowska J., Malecka L., Juraszynski Z. et al. Constriction of the LMCA. Early and long term treatment outcome Kardiol Pol. 1992; 37 (12): р. 363 –

367.Abstract.

78.Kosuga K., Ueda K. et al. Initial and long-term results of angioplasty in unprotected LMCA. Am J Cardiol. 1999; 83 (1): р. 32 – 37.

79.Laham R.J., Baim D.S. Treatment of unprotected LM stenoses with PalmazSchatz stenting. Cathet Cardiovasc Diagn. 1996; 37 (1): р. 77 – 80.

80.Lee S.H., Jang Y. et al. SES versus PES Implantation for Unprotected LMCA Stenosis. Cardiology. 2005; 8; 104 (4): р. 181 – 185.

81.Lefevre T., Silvestri M. et al. The French Registry of Unprotected LMCA Treatment. Final results. TCT 2003. Abstract.

82.Lemos P.A., van Domburg R.T. et al. Unrestricted Utilization of SirolimusEluting Stents Compared With Conventional BMS Implantation in the “Real World”: The Rapamycin-Eluting Stent (DES) Ealuated At Rotterdam Cardiology Hospital (RESEARCH) Registry. Circulation. 2004; 109 (2): р.

190– 195.

83.Levine GN, Bates ER., et al . 2011 ACCF/AHA/SCAI Guideline for PCI. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions J. Am Coll Cardiol. 2011 Dec 6;58(24):e44-122. doi: 10.1016/j.jacc.2011.08.007. Epub 2011 Nov 7.

84.Marco J. Unprotected LM Stenting. The Paris Course on revascularization. 2000. р. 65 – 79.

85.Mauri L, Hsieh W, Massaro JM et al. Stent thrombosis in randomized clinical

136

trials of drug-eluting stents. N Engl J Med 2007; 356: 1020-1029.

86.McArdle H., Bhandari M., Kovac J. Emergency coronary stenting of unprotected critical LMCA stenosis in acute MI and cardiogenic shock. Heart. 2003; 89 (9): р. e24.

87.Medina A, Surez de Lezo J, Pan M. A new classification of coronary bifurcation lesions. Rev Esp cardiol 2006; 59 (2): 183-184.

88.Miller D.W. Jr, Tobis F.M., Ivey T.D. et al. Risks of coronary arteriography and bypass surgery in patients with LMCA stenosis. Chest. 1981; 79 (4): р. 387 – 392.

89.Moosvi A.R., Khaja F., Villanueva L. et al. Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarction. J Am

Coll Cardiol. 1992; 19 (5): р. 639 – 646.

90.Miketic S., Carlsson J., Neuhaus K. et al. Percutaneous transluminal coronary angioplasty of LM stenosis - results of the German PTCA registry. Z Kardiol. 2000; 89 (6): р. 508 – 512.

91.O'Keefe J.H. Jr, Hartzler G.O., Rutherford B.D. et al. LMCA angioplasty: early and late results of 127 acute and elective procedures. Am J Cardiol. 1989; 64 (3): р. 144 – 147.

92.Ong AT, Serruys PW, et al. The Senergy between PCI with Taxus LM and Cardiac Surgery (SYNTAX) study design, rationale and run-in phase. Am Heart J. 2006;151:1194-1204.

93.Pan M., de Lezo J.S., Medina A. et al. Simple and complex stent strategies for bifurcated coronary arterial stenosis involving the side branch origin. Am J Cardiol. 1999; 83 (9): р. 1320 – 1325.

94.Park S.J., Park S.W., Hong M.K. et al. PCI of unprotected LMCA stenoses: immediate and late outcomes. J Am Coll Cardiol. 1998; 31 (1): p. 37 – 42.

95.Park SJ, Hong MK, Lee CW, et al. Elective stenting of unprotect ed LMCA stenosis: effect of debulking before stenting and intravascular ultrasound

guidance. J Am Coll Cardiol 2001;38:1054-60.

137

96.Park DW, Seung KB, Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 5-year results from the MAIN-COMPARE (Revascularization for Unprotected LMCA Stenosis: Comparison of PTCA Versus CABG Revascularization) registry. J Am Coll Cardiol. 2010 Jul 6;56(2):117-24. doi: 10.1016/j.jacc.2010.04.004. Epub 2010 May

97.Park SJ, Hong MK, et al. Long-term (three-year) outcomes after stenting of unprotected LMCA stenosis in patients with normal left ventricular function. Am J Cardiol 2003;91:12-6.

98.Park S.J., Lee S.W. et al. Electie Unprotected LMCA Stenting in the Era of the Drug-Eluting Stent. Am J Cardiol. 2004; 94 (suppl 6A): 1E.

99.Park S.J., Lee B.K. et al. SES implantation for unprotected LMCA stenosis: comparison with BMS implantation. J Am Coll Cardiol. 2005; 1; 45 (3): р. 351 – 356.

100.Park S.J., Park D.W.; Randomized trial of stents versus bypass surgery for LMCA disease. N Engl J Med. 364 2011:1718-1727.

101.Rogers W.J., Fisher L.D. et al. Comparison of the cumulative survival among patient groups with a LMCA lesion after surgical and therapeutic treatment Kardiologiia. 1982; 22 (2): p. 53 – 57.

102.Ryan T.J., Gunnar R.M. et al. Guidelines for Percutaneous Transluminal Coronary Angioplasty: (Subcommittee on PTCAy). Circulation. 1988; 78 (2): p. 486 – 502.

103.Saint-Pierre A., Jamet C. et al. Significance of atheromatous stenoses of the common trunk of the left coronary artery. Arch Mal Coeur Vaiss. 1974; 67 (11): p. 1305 – 1315.

104.Sakai K, Kimura T, et al. Primary angioplasty of unprotected LMCA for acute anterolateral MI. J Invasive Cardiol 2004;16:621-5.

138

105.Sanmartín M, Claro R et al. Comparison of DES versus CABG for unprotected left main coronary artery disease. Am J Cardiol.2007 Sep 15;100(6):970-3.

106.Seung K.B., Park D.W. et al. Effectiveness of SES implantation for the treatment of ostial left anterior descending artery stenosis with intravascular ultrasound guidance. J Am Coll Cardiol. 2005; 6; 46 (5): р. 787 – 792

107.Seung KB, Kim YH et al. Stents versus Coronary-Artery Bypass Grafting for LMCA Disease. N Engl J Med 2008;358: 1-12.

108.Serruys PW, Ong AT, Morice MC, et al. Arterial revascularisation therapies study part II—sirolimus-eluting stents for the treatment of patients with multivessel de novo CA lesions. Euro Intervention 2005;1:147-156.

109.Serruys PW, The surgery between PCI with TAXUS and Cardiac Surgery. The SYNTAX study, 2012(23/10/), pp. 134-142

110.Sganzerla P., Passaretti B., et al. Cardiogenic shock due to acute LMCA occlusion: successful treatment with primary angioplasty. Ital Heart J. 2000; 1 (10): p. 702 – 704.

111.Sharma K.S.,Kamran M. et al. Intervention of Unprotected LM Stenosis in High-Risk Patients: Predictors of TLR at 1 Year. Am J Cardiol. 2001; 88 (suppl 5A): 6G. Abstract.

112.Sheiban I., Decio A., et al. Coronary Angioplasty in Unprotected LMCA in the Eldery (>75 Years): Immediate and Medium–Term Clinical Outcome Am J Cardiol. 2001; 88 (suppl 5A): 36G. Abstract.

113.Sheiban I., Montaldo T, Moretti C. et al. PCI for Unprotected LMCA in Elderly Patients (>75 Years): Immediate and Midterm Clinical Outcome Am J Cardiol. 2002; 90 (suppl 6A): 43H. Abstract.

114.Silber S, Albertsson P, Aviles FF et al. Cuidelines PCI. Eur Heart J 2005; 26;8: 804-847.

139

115.Silvestri M., Sainsous J, Barragan P.,. et al. Unprotected LMCA stenting: immediate and medium-term outcomes of 140 elective procedures. J Am Coll Cagdiol. 2000; 35 (6): p. 1543 – 1550.

116.Smith SC, Hirsgfeld JW, Feldman TE, et al. ACC/AHA/SCAI 2005 Guideline Update for PCI. JACC, 2006; 47: 1-121.

117.Spaulding C, Daemen J, Boersma E et al. A pooled analysis of data comparing sirolimus-eluting stents with bare metal stents. N Engl J Med 2007; 356: 989-997.

118.Sperker W., Gyongyosi M., Kiss K. et al. Shortand Long-Term Results of Emergancy and Elective PCI of LMCA Stenoses. Cath. And Cardiovas. Intervantions. 2002; 56 (1): p. 22 – 29.

119.Stettler C, Wandel S, Allemann S et al. Outcomes associated with DES and BMS: a collaborative network meta-analysis. Lancet 2007; 370: 937-948.

120.Stone G, Moses JW, Ellis SG et al. Safety and efficasy of SESand PES. N Engl J Med 2007; 356: 998-1008.

121.Takagi T., Finci L. Stankovic G., et al. Results and Long-Term Predictors of Adverse Clinical Events After Elective PCI on Unprotected LMCA. Circulation. 2002; 106 (6): p. 698 – 702.

122.Tamai H., Tan W.A., Park S.J. et al. Long-Term Clinical Outcomes After Unprotected LM Trunk Percutaneous Revascularization in 279 Patients. Circulation. 2001; 104 (14): p. 1609 – 1614.

123.Takagi T, Stankovic G, Finci L, et al. Results and long-term predictors of adverse clinical events after elective PCI on unprotected LMCA. Circulation 2002;106: 698-702.

124.Urban P, Guagliumi G, et al. Safety of coronary SES in daily clinical practice: one-year follow-up of the e-Cypher register. Circulation 2006;113: 1434-41.

125.Valgimigli M., van Mieghem CA, Ong AT et al.Shortand Long-Term

Clinical Outcome After DES Implantation for the PCI of LMCA Disease

Insights From the Rapamycin-Eluting and Taxus Stent Evaluated At

140